Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Neil Butt is listed as Chief Executive Officer at Orbit Discovery at Orbit Discovery, based in Oxford, England, United Kingdom. AeroLeads shows a matched LinkedIn profile for Neil Butt.
Neil Butt previously worked as Chief Executive Officer at Orbit Discovery and Chief Business Officer at Iontas (Antibodies). Neil Butt holds Phd, Molecular Microbiology from University Of Southampton.
This section adds company-level context without repeating Neil Butt's masked contact details.
Review company-level records connected to Neil Butt before choosing the right outreach path.
SENIOR EXECUTIVE Global reputation for growing and developing businesses with a focus on services in biologic drug development. Impressive track record of commercialising novel and proprietary technologies for peptide discovery, scaffold and antibody (including bead based functional screening, mammalian display, deimmunisation, immunogenicity assessment ADC's, cell line development and cGMP manufacturing). Respected for growing platform based companies for early seed funding through to exit. Core competencies include negotiating multiple business deals, developing clear marketing strategy and implementing strategies for year on year growth. Exceptionally well-versed in all aspects of strategic business development with an impressive track record of generating multimillion-dollar turnover from both license based and immediate service based revenue streams. Active executive management (as CEO and CBO) for >20 years that has encompassed selling three companies, acquiring two companies, listing on the London Stock Exchange AIM market and multiple in-licencing dealsSIGNATURE STRENGTHSCommercialising Proprietary TechnologiesExecutive ManagementGrowing and Developing Start-up BusinessesBusiness Development & PlanningContract Negotiations, & ReviewsStrategic PlanningTeam LeadershipStrong Scientific Background
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Oxford, GB
Chief Executive Officer of Orbit Discovery a functional screening service company focused on the use of novel bead and microfluidic technology platforms to improve the throughput of functional screening, when searching for agonist of antagonists. The Orbit technologies encompass target protein expression and purification, with a focus on GPCRs; affinity.
Porto, Porto, PT
Head of business development and corporate development activities for IONTAS, a antibody discovery and licensing company. IONTAS have developed and are offering mammalian display and phage display services and also technology licensing opportunities for both bespoke phage display libraries and mammalian display. IONTAS was also acquired by FairJourney.
San Diego, California, US
Head of business development activities for Abzena and part of the executive management team. After the acquisition of Antitope by Polytherics, the joint group became Abzena. The company focused on the development of better biopharmaceuticals by the assessment and removal immunogenicity from therapeutic proteins and peptides and in the development of ADCs.
Led all business development and corporate activities for Antitope and established the company as a brand leader in the assessment and removal of immunogenicity from therapeutic antibodies and proteins. Member of the company Executive Management team which oversaw year on year double digit growth and the eventual acquisition by Polytherics in 2013.
London, London, GB
Primary roles included development of commercial opportunities for novel technologies within the healthcare industry, R&D management; product development within the healthcare industry; and interim management in small and start up companies (primarily business develpment and programme management functions). Key interim roles included:IMI Norgren - Buisness.
Initially R&D Manager for UK Biosciences Group developing new technologies for DNA purification. Collaborated closely with US and other UK research groups to develop technologies associated with both diagnostics and pharmaceutical industries. Switched to marketing and business development group in 1998 and focused on new technologies and novel applications.
Head of Research and Development for a start up company (CMT) developing novel technologies for DNA purification and analysis. Took over R&D management from founder within 12 months of joining company and developed technologies which changed the company strategy. Set up a small service based group within the company to drive revenues and increase turnover..
Quick answers generated from the profile data available on this page.
Neil Butt works for Orbit Discovery.
Neil Butt is listed as Chief Executive Officer at Orbit Discovery at Orbit Discovery.
Neil Butt is based in Oxford, England, United Kingdom while working with Orbit Discovery.
Neil Butt has worked for Orbit Discovery, Iontas (Antibodies), Abzena, Antitope Limited, and Pa Consulting Group.
You can use AeroLeads to view verified contact signals for Neil Butt at Orbit Discovery, including work email, phone, and LinkedIn data when available.
Neil Butt holds Phd, Molecular Microbiology from University Of Southampton.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts